Tan DCS; Yao S; Ittner A; Bertz J; Ke YD; Ittner LM; Delerue F, 2018, 'Generation of a New Tau Knockout (tau Δex1) Line Using CRISPR/Cas9 Genome Editing in Mice', Journal of Alzheimer's Disease, vol. 62, pp. 571 - 578, http://dx.doi.org/10.3233/JAD-171058

Ittner A; Chua SW; Bertz J; Volkerling A; van der Hoven J; Gladbach A; Przybyla M; Bi M; van Hummel A; Stevens CH, 2017, 'Site-specific phosphorylation of tau inhibits amyloid-beta toxicity in Alzheimer's mice (vol 354, 904, 2016)', SCIENCE, vol. 355, http://dx.doi.org/10.1126/science.aam9523

Bi M; Gladbach A; Van Eersel J; Ittner A; Przybyla M; Van Hummel A; Chua SW; Hoven JVD; Lee WS; Müller J, 2017, 'Tau exacerbates excitotoxic brain damage in an animal model of stroke', Nature Communications, vol. 8, http://dx.doi.org/10.1038/s41467-017-00618-0

Moujalled D; Grubman A; Acevedo K; Yang S; Ke YD; Moujalled DM; Duncan C; Caragounis A; Perera ND; Turner BJ, 2017, 'TDP-43 mutations causing amyotrophic lateral sclerosis are associated with altered expression of RNA-binding protein hnRNP K and affect the Nrf2 antioxidant pathway', Human Molecular Genetics, vol. 26, pp. 1732 - 1746, http://dx.doi.org/10.1093/hmg/ddx093

Ahmed RM; Irish M; van Eersel J; Ittner A; Ke YD; Volkerling A; van der Hoven J; Tanaka K; Karl T; Kassiou M, 2017, 'Mouse models of frontotemporal dementia: A comparison of phenotypes with clinical symptomatology', Neuroscience and Biobehavioral Reviews, vol. 74, pp. 126 - 138, http://dx.doi.org/10.1016/j.neubiorev.2017.01.004

Tan RH; Ke YD; Ittner LM; Halliday GM, 2017, 'ALS/FTLD: experimental models and reality', Acta Neuropathologica, vol. 133, pp. 177 - 196, http://dx.doi.org/10.1007/s00401-016-1666-6

Ittner A; Chua SW; Bertz J; Volkerling A; Van Der Hoven J; Gladbach A; Przybyla M; Bi M; Van Hummel A; Stevens CH, 2016, 'Site-specific phosphorylation of tau inhibits amyloid-β toxicity in Alzheimer's mice', Science, vol. 354, pp. 904 - 908, http://dx.doi.org/10.1126/science.aah6205

Van Hummel A; Bi M; Ippati S; Van Der Hoven J; Volkerling A; Lee WS; Tan DCS; Bongers A; Ittner A; Ke YD, 2016, 'No overt deficits in aged tau-deficient C57Bl/6.Mapt^tm1(EGFP)kit GFP knockin mice', PLoS ONE, vol. 11, http://dx.doi.org/10.1371/journal.pone.0163236

Rosa E; Mahendram S; Ke YD; Ittner LM; Ginsberg SD; Fahnestock M, 2016, 'Tau downregulates BDNF expression in animal and cellular models of Alzheimer's disease', Neurobiology of Aging, vol. 48, pp. 135 - 142, http://dx.doi.org/10.1016/j.neurobiolaging.2016.08.020

Przybyla M; Stevens CH; van der Hoven J; Harasta A; Bi M; Ittner A; van Hummel A; Hodges JR; Piguet O; Karl T, 2016, 'Disinhibition-like behavior in a P301S mutant tau transgenic mouse model of frontotemporal dementia', Neuroscience Letters, vol. 631, pp. 24 - 29, http://dx.doi.org/10.1016/j.neulet.2016.08.007

Leshchyns'Ka I; Liew HT; Shepherd C; Halliday GM; Stevens CH; Ke YD; Ittner LM; Sytnyk V, 2015, 'Aβ-dependent reduction of NCAM2-mediated synaptic adhesion contributes to synapse loss in Alzheimer's disease', Nature Communications, vol. 6, http://dx.doi.org/10.1038/ncomms9836

Ke YD; van Hummel A; Stevens CH; Gladbach A; Ippati S; Bi M; Lee WS; Krüger S; van der Hoven J; Volkerling A, 2015, 'Short-term suppression of A315T mutant human TDP-43 expression improves functional deficits in a novel inducible transgenic mouse model of FTLD-TDP and ALS', Acta Neuropathologica, vol. 130, pp. 661 - 678, http://dx.doi.org/10.1007/s00401-015-1486-0

Gladbach A; Van Eersel J; Bi M; Ke YD; Ittner LM, 2014, 'ERK inhibition with PD184161 mitigates brain damage in a mouse model of stroke', Journal of Neural Transmission, vol. 121, pp. 543 - 547, http://dx.doi.org/10.1007/s00702-013-1138-2

Ke YD; Suchowerska AK; Van Der Hoven J; De Silva DM; Wu CW; Van Eersel J; Ittner A; Ittner LM, 2012, 'Lessons from Tau-deficient mice', International Journal of Alzheimer's Disease, http://dx.doi.org/10.1155/2012/873270

Ke Y; Dramiga J; Schütz U; Kril JJ; Ittner LM; Schröder H; Götz J, 2012, 'Tau-mediated nuclear depletion and cytoplasmic accumulation of SFPQ in Alzheimer's and Pick's disease.', PloS one, vol. 7, http://dx.doi.org/10.1371/journal.pone.0035678

Ittner A; Ke YD; Van Eersel J; Gladbach A; Götz J; Ittner LM, 2011, 'Brief update on different roles of tau in neurodegeneration', IUBMB Life, vol. 63, pp. 495 - 502, http://dx.doi.org/10.1002/iub.467

van Eersel J; Ke YD; Gladbach A; Bi M; Götz J; Kril JJ; Ittner LM, 2011, 'Cytoplasmic accumulation and aggregation of TDP-43 upon proteasome inhibition in cultured neurons', PLoS ONE, vol. 6, http://dx.doi.org/10.1371/journal.pone.0022850

Bi M; Ittner A; Ke YD; Götz J; Ittner LM, 2011, 'Tau-targeted immunization impedes progression of neurofibrillary histopathology in aged P301L tau transgenic mice', PLoS ONE, vol. 6, http://dx.doi.org/10.1371/journal.pone.0026860

Ittner LM; Ke YD; Delerue F; Bi M; Gladbach A; van Eersel J; Wölfing H; Chieng BC; Christie MJ; Napier IA, 2010, 'Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models.', Cell, vol. 142, pp. 387 - 397, http://dx.doi.org/10.1016/j.cell.2010.06.036

Götz J; Lim YA; Ke YD; Eckert A; Ittner LM, 2010, 'Dissecting Toxicity of Tau and β-Amyloid', Neurodegenerative Diseases, vol. 7, pp. 10 - 12, http://dx.doi.org/10.1159/000283475

Van Eersel J; Ke YD; Liu X; Delerue F; Kril JJ; Götz J; Ittner LM, 2010, 'Sodium selenate mitigates tau pathology, neurodegeneration, and functional deficits in Alzheimer's disease models', Proceedings of the National Academy of Sciences of the United States of America, vol. 107, pp. 13888 - 13893, http://dx.doi.org/10.1073/pnas.1009038107

Schonrock N; Ke YD; Humphreys D; Staufenbiel M; Ittner LM; Preiss T; Götz J, 2010, 'Neuronal microrna deregulation in response to Alzheimer's disease amyloid-β', PLoS ONE, vol. 5, http://dx.doi.org/10.1371/journal.pone.0011070

Ittner LM; Ke YD; Götz J, 2009, 'Phosphorylated Tau interacts with c-Jun N-terminal kinase-interacting protein 1 (JIP1) in Alzheimer disease', Journal of Biological Chemistry, vol. 284, pp. 20909 - 20916, http://dx.doi.org/10.1074/jbc.M109.014472

Van Eersel J; Bi M; Ke YD; Hodges JR; Xuereb JH; Gregory GC; Halliday GM; Götz J; Kril JJ; Ittner LM, 2009, 'Phosphorylation of soluble tau differs in Pick's disease and Alzheimer's disease brains', Journal of Neural Transmission, vol. 116, pp. 1243 - 1251, http://dx.doi.org/10.1007/s00702-009-0293-y

Ke YD; Delerue F; Gladbach A; Götz J; Ittner LM, 2009, 'Experimental diabetes mellitus exacerbates Tau pathology in a transgenic mouse model of Alzheimer's disease', PLoS ONE, vol. 4, http://dx.doi.org/10.1371/journal.pone.0007917

Fath T; Ke YD; Gunning P; Götz J; Ittner LM, 2009, 'Primary support cultures of hippocampal and substantia nigra neurons', Nature Protocols, vol. 4, pp. 78 - 85, http://dx.doi.org/10.1038/nprot.2008.199

Ittner LM; Fath T; Ke YD; Bi M; Van Eersel J; Li KM; Gunning P; Götz J, 2008, 'Parkinsonism and impaired axonal transport in a mouse model of frontotemporal dementia', Proceedings of the National Academy of Sciences of the United States of America, vol. 105, pp. 15997 - 16002, http://dx.doi.org/10.1073/pnas.0808084105

Götz J; David D; Hoerndli F; Ke YD; Schonrock N; Wiesner A; Fath T; Bokhari L; Lim YA; Deters N, 2008, 'Functional genomics dissects pathomechanisms in tauopathies: Mitosis failure and unfolded protein response', Neurodegenerative Diseases, vol. 5, pp. 179 - 181, http://dx.doi.org/10.1159/000113696

Götz J; Deters N; Doldissen A; Bokhari L; Ke Y; Wiesner A; Schonrock N; Ittner LM, 2007, 'A decade of tau transgenic animal models and beyond', Brain Pathology, vol. 17, pp. 91 - 103, http://dx.doi.org/10.1111/j.1750-3639.2007.00051.x

Schild A; Schmidt K; Lim YA; Ke Y; Ittner LM; Hemmings BA; Götz J, 2006, 'Altered levels of PP2A regulatory B/PR55 isoforms indicate role in neuronal differentiation', International Journal of Developmental Neuroscience, vol. 24, pp. 437 - 443, http://dx.doi.org/10.1016/j.ijdevneu.2006.08.005